[Pathomechanism and pharmacological treatment of Parkinson's disease].
D000109:Acetylcholine; D000470:Alkaloids / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000378:metabolism; D006651:Histocytochemistry; D006801:Humans; D009638:Norepinephrine / Q000378:metabolism; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D010672:Phenytoin / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism; D013378:Substantia Nigra / Q000473:pathology
D000470:Alkaloids; D010276:Parasympatholytics; D012701:Serotonin; D010672:Phenytoin; D004295:Dihydroxyphenylalanine; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine
Współczesne poglady na patomechanizm i leczenie farmakologiczne choroby Parkinsona.